Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 67

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 67
---
 applicable prospectus supplement relating
to a particular series of units.

The following description, together with the additional
information included in any applicable prospectus supplement, summarizes the general features of the units that we may offer under this
prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related
to the series of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements
will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus
is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to
units offered under this prospectus.

If we offer any units, certain terms of that series
of units will be described in the applicable prospectus supplement, including, without limitation, the following, as applicable:

| ● | the title of the series of units; |

| ● | identification and description of the separate constituent securities comprising the units; |

| ● | the price or prices at which the units will be issued; |

| ● | the date, if any, on and after which the constituent securities comprising the units will be separately transferable; |

| ● | a discussion of certain United States federal income tax considerations applicable to the units; and |

| ● | any other terms of the units and their constituent securities. |

<div align='center'>20

CERTAIN PROVISIONS
OF DELAWARE LAW AND OF THE COMPANY’S CERTIFICATE OF INCORPORATION AND BYLAWS</div>

Anti-Takeover Provisions

The provisions of Delaware law, the Certificate
of Incorporation and the Bylaws could have the effect of delaying, deferring or discouraging another person from acquiring control of
us. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part,
to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of
increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging
a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms.

Delaware Law

We are subject to Section 203 of the Delaware
General Corporation Law (the “DGCL”), an anti-takeover law. In general, Section 203